Tessa Therapeutics Appoints Wilson W. Cheung As Chief Financial Officer
25+ year industry executive to oversee Tessa’s financial management, investor relations, and business development strategy SINGAPORE, April 5 (Bernama-GLOBE NEWSWIRE) —Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced the appointment of Wilson W. Cheung as its chief financial…

